Cargando…

Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA

BACKGROUND: The purpose of this study was to identify the causes, clinical features, and outcomes of intermediate uveitis, posterior uveitis, and panuveitis in patients managed in a mid-Atlantic tertiary care center. METHODS: This was a retrospective observational study of intermediate uveitis, post...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelhard, Stephanie B, Patel, Vandan, Reddy, Ashvini K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556262/
https://www.ncbi.nlm.nih.gov/pubmed/26345421
http://dx.doi.org/10.2147/OPTH.S89428
_version_ 1782388326631735296
author Engelhard, Stephanie B
Patel, Vandan
Reddy, Ashvini K
author_facet Engelhard, Stephanie B
Patel, Vandan
Reddy, Ashvini K
author_sort Engelhard, Stephanie B
collection PubMed
description BACKGROUND: The purpose of this study was to identify the causes, clinical features, and outcomes of intermediate uveitis, posterior uveitis, and panuveitis in patients managed in a mid-Atlantic tertiary care center. METHODS: This was a retrospective observational study of intermediate uveitis, posterior uveitis, and panuveitis patients seen at the University of Virginia from 1984 to 2014. RESULTS: One hundred and fifty-nine intermediate uveitis, posterior uveitis, and panuveitis patients (237 eyes) were identified. The patient population was 54.72% female; 67.30% of patients were Caucasian, and 22.01% were African–American. Mean age at diagnosis was 45.5 years. Mean duration of follow-up was 3.95 years. Mean number of visits to the clinic was 10.35. Of 491 uveitis patients, 26 (5.30%) had intermediate uveitis, 62 (12.60%) had posterior uveitis, and 71 (14.50%) had panuveitis. The leading diagnoses in the intermediate uveitis group were pars planitis (73.08%) and sarcoidosis (11.54%); toxoplasma uveitis (17.74%), multifocal choroiditis (14.52%), undifferentiated posterior uveitis (14.52%), and birdshot chorioretinitis (11.29%) in the posterior uveitis group; and undifferentiated panuveitis (29.58%), post-surgical panuveitis (18.31%), sarcoidosis (12.68%), acute retinal necrosis (12.68%), and toxoplasma uveitis (4.23%) in the panuveitis group. The most common treatment modalities included local steroids (57.23%) and systemic steroids (42.14%). Ocular hypertension was found in 38 patients (23.90%). Glaucoma surgery was performed in 18.24% of patients and cataract surgery in 21.38%. Mean best-corrected visual acuity was 0.66 logMAR at baseline across all anatomical locations and 0.57 logMAR at final follow-up. Best-corrected visual acuity improved or remained stable during follow-up in all groups. CONCLUSION: The most common diagnoses in our series by anatomical location were pars planitis (intermediate uveitis), toxoplasmosis (posterior uveitis), and undifferentiated uveitis (panuveitis). Panuveitis had significantly worse visual outcomes and higher rates of complications than did intermediate or posterior uveitis, a finding that confirms earlier reports. In this series, unilateral disease, regardless of anatomical location, was associated with poorer visual outcome, in contrast with the findings of other reports.
format Online
Article
Text
id pubmed-4556262
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45562622015-09-04 Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA Engelhard, Stephanie B Patel, Vandan Reddy, Ashvini K Clin Ophthalmol Original Research BACKGROUND: The purpose of this study was to identify the causes, clinical features, and outcomes of intermediate uveitis, posterior uveitis, and panuveitis in patients managed in a mid-Atlantic tertiary care center. METHODS: This was a retrospective observational study of intermediate uveitis, posterior uveitis, and panuveitis patients seen at the University of Virginia from 1984 to 2014. RESULTS: One hundred and fifty-nine intermediate uveitis, posterior uveitis, and panuveitis patients (237 eyes) were identified. The patient population was 54.72% female; 67.30% of patients were Caucasian, and 22.01% were African–American. Mean age at diagnosis was 45.5 years. Mean duration of follow-up was 3.95 years. Mean number of visits to the clinic was 10.35. Of 491 uveitis patients, 26 (5.30%) had intermediate uveitis, 62 (12.60%) had posterior uveitis, and 71 (14.50%) had panuveitis. The leading diagnoses in the intermediate uveitis group were pars planitis (73.08%) and sarcoidosis (11.54%); toxoplasma uveitis (17.74%), multifocal choroiditis (14.52%), undifferentiated posterior uveitis (14.52%), and birdshot chorioretinitis (11.29%) in the posterior uveitis group; and undifferentiated panuveitis (29.58%), post-surgical panuveitis (18.31%), sarcoidosis (12.68%), acute retinal necrosis (12.68%), and toxoplasma uveitis (4.23%) in the panuveitis group. The most common treatment modalities included local steroids (57.23%) and systemic steroids (42.14%). Ocular hypertension was found in 38 patients (23.90%). Glaucoma surgery was performed in 18.24% of patients and cataract surgery in 21.38%. Mean best-corrected visual acuity was 0.66 logMAR at baseline across all anatomical locations and 0.57 logMAR at final follow-up. Best-corrected visual acuity improved or remained stable during follow-up in all groups. CONCLUSION: The most common diagnoses in our series by anatomical location were pars planitis (intermediate uveitis), toxoplasmosis (posterior uveitis), and undifferentiated uveitis (panuveitis). Panuveitis had significantly worse visual outcomes and higher rates of complications than did intermediate or posterior uveitis, a finding that confirms earlier reports. In this series, unilateral disease, regardless of anatomical location, was associated with poorer visual outcome, in contrast with the findings of other reports. Dove Medical Press 2015-08-25 /pmc/articles/PMC4556262/ /pubmed/26345421 http://dx.doi.org/10.2147/OPTH.S89428 Text en © 2015 Engelhard et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Engelhard, Stephanie B
Patel, Vandan
Reddy, Ashvini K
Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title_full Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title_fullStr Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title_full_unstemmed Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title_short Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
title_sort intermediate uveitis, posterior uveitis, and panuveitis in the mid-atlantic usa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556262/
https://www.ncbi.nlm.nih.gov/pubmed/26345421
http://dx.doi.org/10.2147/OPTH.S89428
work_keys_str_mv AT engelhardstephanieb intermediateuveitisposterioruveitisandpanuveitisinthemidatlanticusa
AT patelvandan intermediateuveitisposterioruveitisandpanuveitisinthemidatlanticusa
AT reddyashvinik intermediateuveitisposterioruveitisandpanuveitisinthemidatlanticusa